Saturday 17 October 2026
Export SOLS’s income statement to Excel — free account
Solstice Advanced Materials Inc.
SOLS Basic Materials Specialty Chemicals
Solstice Advanced Materials Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 3.08% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS fell 15.0%, free cash flow grew 70.8% and total debt rose 5,486.5%, each against the same quarter a year earlier.
59.25
0.67
−1.12%
Follow SOLS
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/E ratio |
33.17 | 33.17 | 33.17 |
P/S ratio |
1.98 | 2.02 | 2.02 |
Altman Z-Score |
2.27 | — | — |
P/FCF ratio |
54.29 | 31.48 | 31.48 |
Altman Z″-Score (non-manufacturers) |
1.87 | — | — |
Beneish M-Score |
(3.19) | — | — |
P/Operating CF |
46.44 | (365.77) | (365.77) |
P/B ratio |
5.60 | 2.41 | 2.41 |
Price to Tangible BV |
15.18 | 3.31 | 3.31 |
EV/Sales |
2.38 | 1.94 | 1.94 |
EV/EBITDA |
11.08 | 8.31 | 8.31 |
EV/Operating CF |
20.33 | 13.07 | 13.07 |
EV/FCF |
65.15 | 30.21 | 30.21 |
Quick Ratio |
0.69 | 1.14 | — |
Current Ratio |
1.39 | 1.72 | — |
Net Debt/EBITDA |
1.85 | (0.61) | 0.00 |
Debt/Assets |
36.59% | 0.74% | 0.00% |
Debt/Equity |
1.51 | 0.01 | 0.00 |
Asset Turnover |
0.73 | 1.51 | 0.00 |
Operating CF/Net income |
1.92 | 1.42 | 1.22 |
Capex/Depreciation |
(1.50) | (1.36) | (1.30) |
Interest Coverage |
21.96 | 61.92 | 51.44 |
| 10.40% | 0.00% | 0.00% | |
| 4.44% | 23.74% | 0.00% | |
ROIC |
13.17% | 19.67% | 0.00% |
Return on Tangible Assets |
8.68% | 23.53% | 0.00% |
Average Days of Receivables |
60.58 | 55.09 | 0.00 |
Research and Development Expense of Revenue |
2.50% | 2.20% | 2.22% |
Selling, General and Administrative Expense of Revenue |
10.83% | 10.40% | 10.36% |
Intangible Assets out of Total Assets |
0.15 | 0.17 | 0.00 |
Share Based Compensation of Revenue |
0.69% | 0.45% | 0.49% |
Graham Net Nets |
(0.25) | (0.02) | (0.02) |
Graham Number |
0.00 | 0.00 | 0.00 |
Earnings Yield |
3.01% | 3.01% | 3.01% |
Free Cash Flow Yield |
1.84% | 3.18% | 3.18% |
Revenue per Share |
24.49 | 23.76 | 22.99 |
Operating CF per Share |
2.87 | 5.31 | 4.79 |
Capex per Share |
(2.07) | (1.87) | (1.81) |
Free Cash Flow per Share |
0.79 | 3.44 | 2.97 |
Cash per Share |
3.36 | 4.17 | 0.00 |
Shareholders Equity per Share |
8.68 | 20.05 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
8.68 | 20.05 | 0.00 |
Free Cash Flow |
126.00 | 546.00 | 472.00 |
Working Capital |
675.00 | 778.00 | — |
Capital Expenditures |
(329.00) | (296.00) | (288.00) |
Net Current Asset Value |
(1,908.00) | 39.00 | 0.00 |
EV/EBIT |
15.04 | 10.22 | 10.22 |
Capex to Sales |
0.08 | 0.08 | 0.08 |
Price to Operating Income |
12.54 | 10.65 | 10.65 |
| Other line items | |||
Depreciation/Fixed assets |
0.11 | 0.12 | 0.00 |
Cash ROIC |
3.16% | 14.07% | 0.00% |
Accounts Receivable Turnover |
6.40 | 0.00 | 0.00 |
Accounts Payable Turnover |
3.13 | 0.00 | 0.00 |
Inventory Turnover |
4.14 | 0.00 | 0.00 |
Average Days of Payables |
125.87 | 115.25 | 0.00 |
Days of Inventory on Hand |
99.00 | 82.66 | 0.00 |
Average Receivables |
607.00 | — | — |
Average Payables |
843.50 | — | — |
Average Inventory |
636.50 | — | — |
Average Assets |
5,338.50 | 2,502.00 | — |
Average Common Equity |
2,279.50 | — | — |
Columns are period end dates